Veriheal

JANUARY 4, 2021

In adults with chronic pain, what are the harms of cannabinoids? In adults with chronic pain, what are the benefits of cannabinoids? Cannabis is a plant loaded with cannabinoids like THC , CBN , CBG , CBD , and others. Medicinal cannabinoid therapies are saving and changing lives for people across America and around the world.

Chronic Pain 105

Chronic Pain Therapy Cannabinoids Treatment 105

Greencamp

FEBRUARY 2, 2019

Even though cannabis and cannabinoid-derived pharmaceuticals are both frequently used by HIV/AIDS patients, several studies show that something interesting happens when cannabis is consumed. These medications are combined in what’s known as HAART (highly active antiretroviral therapy). What is HIV and how is it manifested? 2016 ( 3 ).

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Cannabis Law Report

SEPTEMBER 12, 2021

Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. But do medical cannabinoids actually help animal patients? She sought to make sense of the issues during her presentation “Medical Cannabinoids Revisited” at AVMA Virtual Convention 2021 on Aug.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

The Joint Blog

FEBRUARY 15, 2020

Activiation of the cannabinoid system – which is done naturally through the consumption of cannabis and cannabinoids – may alleviate pain in this with cancer-induced bone pain, according to a new study published in the Journal of Pharmacology and Experimental Therapeutics, and epublished by the National Institute of Health.

Cannabinoids 52

Cannabinoids Therapy Concentrates Data 52

The Cannigma

AUGUST 5, 2022

2 In 2019 the FDA approved a keta m ine-based nasal spray to treat depression that does not respond to other therapies. Though hope remains for using cannabinoids to treat depression, in human studies THC has often been more associated with depressive behavior. Depression and psychedelics. Who could you be if you felt better?

Treatment 141

Treatment Research and Development Therapy Digestion 141

TheAnswerPage

JANUARY 11, 2022

and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ In addition, if clinicians are not well informed about the health effects of cannabinoid-based products, clinicians will not be able to optimally treat their patients. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

The Cannigma

FEBRUARY 2, 2021

Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.

Patients 98

Patients Clinical Trials Research and Development Treatment 98

Veriheal

MAY 26, 2022

Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. Of course, legalization and education efforts can only go so far without data, and that’s where RoC’s research initiatives come into play.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

The Joint Blog

FEBRUARY 8, 2020

Treatment with marijuana significantly reduces symptoms in patients with refractory gastroparesis, according to clinical data published in the journal Cureus, and first reported on by NORML. Cannabinoids are increasingly used for medicinal purposes, including neuropathy. Cannabinoids dramatically improve the symptoms of gastroparesis.

Marijuana 72

Marijuana Cannabinoids Treatment Therapy 72

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. We could potentially develop north of 11,000 drugs that are cannabinoid-based. This means that U.S.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 122

Research and Development Data THC Clinical Trials 122

The Joint Blog

FEBRUARY 27, 2019

Cannabinoids “may be an effective adjunct for the treatment of pancreatic cancer”, according to a new study. The study, titled Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer, was published by the Journal of Pancreatic Cancer, and has been epublished by the National Institute of Health.

Treatment 46

Treatment Cannabinoids Patients Therapy 46

LifeCannMD

MAY 27, 2025

” His research, published in Cannabis and Cannabinoid Research , demonstrates that low doses of THC can actually produce opposite effects from high doses. Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

Cannabis Law Report

JULY 8, 2021

Seeks To Identify Novel Cannabinoids For Therapeutic Use. The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. CHARLOTTE, N.C.–(BUSINESS

Research and Development 85

Research and Development Pets Cannabinoids eCommerce 85

The Cannigma

JULY 17, 2022

You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies. The advice and suggestions are based on data, including the results from ROC’s own cannabis research registry.

Advocacy 133

Advocacy Education Events Epilepsy 133

Veriheal

JANUARY 26, 2023

Further exploration of this possibility is underway to provide better care and more effective therapies for individuals living with the condition. Thus, this groundbreaking study laid the foundation for understanding how cannabinoids can support mental health.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

The Cannigma

NOVEMBER 11, 2021

mg total cannabinoids. Researchers analyzed the data self-reported by the 18 participants and found statistically significant differences (which adds power and confidence to the results) between the experimental conditions in many of the items and scales used. CBD alters the subjective effects of THC.

CBD 141

CBD Research and Development THC Environment 141

Veriheal

JUNE 30, 2023

Researchers say this emphasizes just how important it is that psilocybin therapy be done in a controlled setting with therapy and community-based after-care. The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines. For more information, visit www.inmedpharma.com.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

The Joint Blog

MARCH 3, 2021

The study found “significant improvements were observed” following the initiation of cannabis therapy in most patients. The study concludes by stating that “The current study revealed the positive effects of MC [medical cannabis] therapy in some patients with FMS [ fibromyalgia syndrome] and resistance to conventional treatment.

Therapy 61

Therapy Hybrid Marijuana Research and Development 61

Cannabis Law Report

SEPTEMBER 15, 2021

Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant. Some concerns include variability in product formulations and product labeling, other cannabinoid and terpene content, and variable delta-8 THC concentrations. synthetic conversion).

THC 105

THC Pets Events Hemp 105

Veriheal

MARCH 3, 2022

The report titled “ Cannabis, Cannabinoids, and Sleep: a Review of the Literature ,” also revealed that delta-9 tetrahydrocannabinol (THC) may reduce sleep latency. Cannabis, Cannabinoids, and Sleep: What Did the Study Find? Cannabinoids and Sleep: An Area for Further Study. adults between the ages of 20-59.

Sleep 94

Sleep Consumption Cannabinoids Cannabis 94

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Pharmaceutical 76

Pharmaceutical Research and Development Sativa Extraction 76

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. Prevalence and incidence of rare diseases: Bibliographic data.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JUNE 7, 2021

The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day. Securities and Exchange Commission (“SEC”) on July 13, 2020. About IGC: India Globalization Capital, Inc.

Clinical Trials 81

Clinical Trials Patients THC Safety 81

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 40

Pharmaceutical Data CBD Clinical Trials 40

The Cannigma

OCTOBER 9, 2021

Studies demonstrate that cannabis and its cannabinoid constituents have an implication on human urinary function. The common understanding is that every individual has a separate and different reaction to cannabinoid-based therapy, the same is true with how it might influence individual urinary symptoms.

Consumption 97

Consumption Cannabinoids Patients Cannabis 97

CannaMD

MAY 14, 2020

Data from Colorado, which was among the first states to legalize marijuana, indicates that edible cannabis-infused products account for some 45% of all cannabis sales. These figures do not include homemade edibles made from cannabinoid-infused oils, so the actual percentage of use may be higher!).

Edibles 105

Edibles Marijuana THC Vaping 105

TheAnswerPage

JULY 19, 2022

Have researchers found that patients who use cannabidiol (CBD)-rich extract therapy for the treatment of epilepsy require a lower dose of CBD medication as compared to those who use purified CBD therapy for the treatment of epilepsy? Pamplona F, da Silva L and Coan A. 12 September 2018. Sec.Neuropharmacology. See the Answer.

Epilepsy 40

Epilepsy Therapy Extraction Data 40

Cannabis Info

MARCH 2, 2019

The non-psychoactive cannabinoid CBD has gained massive attention due to its apparent positive effects on seizures. However there is some evidence, that THC, a psychoactive cannabinoid, may also be effective in the treatment of the condition. CASE STUDY.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

The Cannigma

MAY 16, 2025

Every gummy, every CBD tincture, every vape pen, every cannabis recommendation is political and will be until cannabis and all its cannabinoids are federally legal. and years of data proving the positive impacts that medical cannabis has on healthcare systems. Cannabis is not safe from shifting political winds and regulatory clawbacks.

Policy 79

Policy Access Advocacy Patients 79

Puff Puff Post

DECEMBER 28, 2018

We go deep into what this might mean for the future of therapy for Autism Spectrum Disorders (ASD), and how we might see the use of CBD oil for autism. An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. Success rates of up to 80% have been observed for CBD related autism therapy.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

DECEMBER 2, 2021

The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. THC is a naturally occurring cannabinoid produced by the cannabis plant. million individuals in the U.S.

Clinical Trials 40

Clinical Trials Data Patients THC 40

Veriheal

NOVEMBER 13, 2020

The data of 87 individuals with OCD who tracked the severity of their intrusions, compulsions, and/or anxiety immediately before and after a total of 1810 cannabis use sessions over a time period of 31 months. . Cannabis can help OCD sufferers and is an all-natural form of therapy, which is gaining more and more support as time goes by. .

Research and Development 98

Research and Development Consumption Patients Strains 98

CannaTech

FEBRUARY 25, 2019

Brainose is currently developing a pharmaceutical-grade cannabinoid-based therapy with a focus on pain management for FDA and CE approval in the U.S. Indorz : Indoor cannabis farming data solution that predicts, analyzes, and automates the grow process to maximize yield and quality. and Europe. Ag-tech and Growing Solutions.

Research and Development 85

Research and Development Hybrid Treatment Strains 85

CannaMD

DECEMBER 9, 2020

Noting that the effects of oral administration of cannabis (edibles) can be less predictable that smoked or vaporized administration of products with similar levels of specific cannabinoids, the AHA cautions: Patients must be made aware that the onset of effects begins within 30 minutes to ?1 CANNABIS: POTENTIAL AND KNOWN BENEFITS.

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Cannabis Law Report

DECEMBER 1, 2019

Suffering from refractory epilepsy, the girl failed to respond to therapies and had exhausted all currently registered medications for treatment, the Ministry of Home Affairs (MHA) told The Sunday Times. Results from the studies cannot be extrapolated to other cannabinoid medications, he added.

Epilepsy 45

Epilepsy Cannabinoids Therapy Treatment 45